Silvant Capital Management LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 25,811 shares of the company’s stock, valued at approximately $3,317,000.
Several other large investors have also recently added to or reduced their stakes in the business. LaSalle St. Investment Advisors LLC bought a new stake in Merck KGaA during the 2nd quarter valued at $2,432,000. Ceredex Value Advisors LLC acquired a new position in Merck KGaA during the 2nd quarter worth $30,371,000. Mystic Asset Management Inc. bought a new position in shares of Merck KGaA in the second quarter worth $2,943,000. Advisors Preferred LLC bought a new position in shares of Merck KGaA in the second quarter worth $401,000. Finally, Oxford Financial Group LTD. LLC acquired a new position in shares of Merck KGaA during the second quarter valued at $536,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $162.12 on Friday. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The firm’s 50-day simple moving average is $162.47 and its 200 day simple moving average is $148.35. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market cap of $20.95 billion, a P/E ratio of 24.75 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
